Abstract
Evidence suggests that perioperative allogeneic blood transfusion increases the risk of infectious complications after major surgery and of cancer recurrence after curative operation. This has been attributed to immuno-suppression. Several authors have suggested that filtered whole blood and/or red cell concentrate, or leucocyte-and buffy coat-reduced red cells in artificial medium or their own plasma, may reduce postoperative immuno-suppression. It was also anticipated that the use of autologous blood might minimize the risk of perioperative transfusion, but studies have unexpectedly shown similar postoperative infectious complications and cancer recurrence and/or survival rates in patients receiving autologous blood donated before operation and those receiving allogeneic blood. Future studies should identify common risk factors associated with blood storage.